COM:ROIVANT
Roivant Sciences Ltd.
- Stock
Last Close
11.82
22/11 21:00
Market Cap
8.31B
Beta: -
Volume Today
11.36M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|
average inventory | 1.38M - | 19.01M 1,276.75% | |||||
average payables | 8.27M - | 27.57M - | 36.21M 31.34% | 45.53M 25.74% | |||
average receivables | 13.12M - | 16.37M - | 57.77M 252.98% | ||||
book value per share | 3.33 - | 9.44 183.44% | 2.63 72.18% | 3.04 15.96% | 2.26 25.92% | 7.62 237.88% | |
capex per share | -0.05 - | -0.02 56.86% | -0.01 62.86% | -0.03 207.05% | -0.02 31.61% | -0.00 90.09% | |
capex to depreciation | -0.67 - | -0.06 90.68% | |||||
capex to operating cash flow | 0.01 - | 0.01 42.00% | 0.01 62.96% | 0.03 144.66% | 0.02 41.52% | 0.00 88.00% | |
capex to revenue | -4.90 - | -0.07 98.52% | -0.24 235.97% | -0.32 29.25% | -0.21 34.34% | -0.01 94.65% | |
cash per share | 3.94 - | 10.15 157.25% | 3.00 70.43% | 3.10 3.19% | 2.37 23.34% | 8.34 251.50% | |
days of inventory on hand | 76.76 - | 826.90 977.19% | |||||
days payables outstanding | 3.75K - | 3.33K 11.41% | 3.65K 9.64% | 1.41K 61.39% | 1.05K 25.29% | 1.25K 18.70% | |
days sales outstanding | 1.72K - | 82.39 95.22% | 194.98 - | 242.21 24.22% | |||
debt to assets | 0.10 - | 0.05 54.44% | 0.09 101.25% | 0.11 16.09% | 0.20 83.45% | 0.07 65.65% | |
debt to equity | 0.20 - | 0.06 71.31% | 0.14 137.84% | 0.14 2.18% | 0.30 115.07% | 0.08 72.04% | |
dividend yield | 0.03 - | ||||||
earnings yield | -0.47 - | 0.54 215.22% | -0.13 125.08% | -0.28 107.79% | -0.23 16.28% | 0.53 327.67% | |
enterprise value | 1.53B - | 235.07M 84.67% | 4.89B 1,978.99% | 1.53B 68.65% | 4.06B 165.33% | 2.13B 47.52% | |
enterprise value over ebitda | 11.10 - | 2.80 74.75% | -9.57 441.49% | -1.02 89.33% | -3.67 259.29% | -2.14 41.67% | |
ev to operating cash flow | -1.50 - | -0.31 79.39% | -8.85 2,768.56% | -2.26 74.46% | -4.82 113.21% | -2.79 42.16% | |
ev to sales | 659.77 - | 3.47 99.47% | 205.39 5,814.04% | 27.71 86.51% | 66.33 139.37% | 17.09 74.23% | |
free cash flow per share | -4.81 - | -3.56 25.96% | -0.81 77.12% | -1.04 27.39% | -1.20 15.71% | -0.98 18.50% | |
free cash flow yield | -0.46 - | -0.34 25.96% | -0.08 75.67% | -0.21 152.20% | -0.16 22.54% | -0.09 42.33% | |
graham net net | 1.89 - | 8.49 348.99% | 2.23 73.73% | 2.28 2.28% | 1.31 42.43% | 7.46 467.93% | |
graham number | 19.04 - | 34.40 80.71% | 8.81 74.39% | 9.72 10.32% | 9.36 3.74% | 30.85 229.72% | |
income quality | 1.37 - | 1.47 7.31% | 0.61 58.19% | 0.73 19.57% | 0.76 3.10% | -0.18 123.92% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.06 Infinity% | 0.02 68.52% | |
interest coverage | -99.32 - | -69.30 30.23% | -381.24 450.13% | -172.10 54.86% | -38.53 77.61% | 121.97 416.58% | |
interest debt per share | 0.70 - | 0.58 17.65% | 0.36 37.22% | 0.43 20.05% | 0.71 64.51% | 0.68 4.50% | |
inventory turnover | 4.75 - | 0.44 90.72% | |||||
invested capital | 0.20 - | 0.06 71.31% | 0.14 137.84% | 0.14 2.18% | 0.30 115.07% | 0.08 72.04% | |
market cap | 2.24B - | 2.24B 0% | 6.70B 199.03% | 3.31B 50.60% | 5.26B 58.99% | 8.17B 55.30% | |
net current asset value | 734.96M - | 1.85B 151.83% | 1.66B 10.35% | 1.60B 3.55% | 1.02B 36.48% | 5.96B 486.08% | |
net debt to ebitda | -5.11 - | -23.91 367.45% | 3.55 114.83% | 1.18 66.59% | 1.08 8.88% | 6.06 461.20% | |
net income per share | -4.84 - | 5.57 215.22% | -1.31 123.58% | -1.38 4.96% | -1.73 25.07% | 5.55 421.76% | |
operating cash flow per share | -4.76 - | -3.54 25.62% | -0.81 77.21% | -1.01 25.50% | -1.18 16.93% | -0.98 17.43% | |
payables turnover | 0.10 - | 0.11 12.87% | 0.10 8.79% | 0.26 159.01% | 0.35 33.85% | 0.29 15.76% | |
receivables turnover | 0.21 - | 4.43 1,991.19% | 1.87 - | 1.51 19.50% | |||
research and ddevelopement to revenue | 220.74 - | 3.89 98.24% | 9.94 155.73% | 8.74 12.14% | 8.57 1.90% | 4.02 53.09% | |
return on tangible assets | -0.75 - | 0.48 164.55% | -0.35 171.73% | -0.36 2.83% | -0.55 53.29% | 0.61 212.02% | |
revenue per share | 0.01 - | 0.31 2,812.61% | 0.03 88.94% | 0.08 137.56% | 0.09 4.15% | 0.16 85.33% | |
roe | -1.45 - | 0.59 140.65% | -0.50 184.76% | -0.45 9.49% | -0.77 68.82% | 0.73 195.23% | |
roic | -0.87 - | -0.24 72.09% | -0.51 107.97% | -0.51 0.18% | -0.50 0.68% | 0.65 229.87% | |
sales general and administrative to revenue | 102.07 - | 4.96 95.14% | 10.92 120.17% | 14.02 28.36% | 9.80 30.10% | ||
shareholders equity per share | 3.33 - | 9.44 183.44% | 2.63 72.18% | 3.04 15.96% | 2.26 25.92% | 7.62 237.88% | |
stock based compensation to revenue | 25.33 - | 1.81 92.85% | 3.57 97.17% | 10.22 186.21% | 3.55 65.22% | 1.60 54.99% | |
tangible asset value | 937.30M - | 2.11B 124.98% | 2.06B 2.21% | 2.04B 1.12% | 1.46B 28.26% | 6.31B 331.44% | |
tangible book value per share | 4.35 - | 9.79 124.98% | 3.01 69.25% | 3.04 1.10% | 2.05 32.59% | 8.06 292.63% | |
working capital | 974.21M - | 2.13B 118.34% | 1.97B 7.48% | 1.96B 0.30% | 1.53B 22.22% | 6.47B 323.62% |
All numbers in (except ratios and percentages)